Skip to main content
Top
Published in: International Urology and Nephrology 10/2016

01-10-2016 | Urology - Original Paper

Treatment strategies for upper tract urothelial carcinoma (UTUC) of a solitary kidney: a single-institutional analysis of 61 cases

Authors: Xiaohong Su, Dong Fang, Lei Zhang, Gengyan Xiong, Han Hao, Guangzhi Zhao, Kunlin Yang, Yunchao Xing, Xuesong Li, Liqun Zhou

Published in: International Urology and Nephrology | Issue 10/2016

Login to get access

Abstract

Objective

To explore the treatment strategies for patients with upper tract urothelial carcinoma (UTUC) of a solitary kidney.

Methods

A retrospective analysis of 61 cases who underwent operation for UTUC of a solitary kidney from 2000 to 2012 was performed. Radical nephroureterectomy (RNU) or conservative management was performed. Patients were divided into three groups according to preoperative renal function: group A (eGFR ≥ 60 mL/min), group B (15 mL/min ≤ eGFR < 60 mL/min) and group C (eGFR < 15 mL/min). We analyzed treatment outcomes of patients with different renal function and surgical approaches.

Results

No significant complications were observed, and short-time recovery after operation was satisfactory in all patients. The 5-year cancer-specific survival (CSS) rates for the groups A, B and C were 92.9, 75.3 and 63.7 %, respectively (p = 0.683). The 5-year overall survival (OS) and recurrence-free survival rates were 92.9 and 53 % for group A, respectively, 75.3 and 64.8 % for group B, respectively, and 63.7 and 29.5 % for group C, respectively (all p > 0.1). The conservative management arm was associated with older age (p = 0.002), smaller tumor size (p = 0.013), lack of renal replacement history (p = 0.007) and better preoperative renal function (p = 0.002). There were no significant differences in 5-year CSS, OS or recurrence-free survival between the RNU and conservative management groups. Long-term hemodialysis was required in only three patients in the conservative management arm.

Conclusion

Long-term oncological outcomes after conservative management are comparable to RNU in selected cases, and conservative management should be considered an alternative treatment measure. Preoperative renal function and clinicopathological characteristics are important in surgery selection for patients with UTUC of a solitary kidney.
Literature
1.
go back to reference Munoz JJ, Ellison LM (2000) Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 164(5):1523–1525CrossRefPubMed Munoz JJ, Ellison LM (2000) Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 164(5):1523–1525CrossRefPubMed
2.
go back to reference Holmang S, Johansson SL (2004) Synchronous bilateral ureteral and renal pelvic carcinomas: incidence, etiology, treatment and outcome. Cancer 101(4):741–747CrossRefPubMed Holmang S, Johansson SL (2004) Synchronous bilateral ureteral and renal pelvic carcinomas: incidence, etiology, treatment and outcome. Cancer 101(4):741–747CrossRefPubMed
3.
go back to reference Fang D, Xiong G, Li X, Kang Y, Zhang L, Zhao G, Chen X, Yao L, Zhang X, Yu W, Gong K, Song Y, He Q, He Z, Zhou L, Guo Y (2015) Incidence, characteristics, treatment strategies, and oncologic outcomes of synchronous bilateral upper tract urothelial carcinoma in the Chinese population. Urol Oncol 33(2):66.e1–66.e11CrossRef Fang D, Xiong G, Li X, Kang Y, Zhang L, Zhao G, Chen X, Yao L, Zhang X, Yu W, Gong K, Song Y, He Q, He Z, Zhou L, Guo Y (2015) Incidence, characteristics, treatment strategies, and oncologic outcomes of synchronous bilateral upper tract urothelial carcinoma in the Chinese population. Urol Oncol 33(2):66.e1–66.e11CrossRef
4.
go back to reference Fang D, Zhang L, Li X, Xiong G, Chen X, Han W, He Z, Zhou L (2014) Risk factors and treatment outcomes of new contralateral upper urinary urothelial carcinoma after nephroureterectomy: the experiences of a large Chinese center. J Cancer Res Clin Oncol 140(3):477–485CrossRefPubMed Fang D, Zhang L, Li X, Xiong G, Chen X, Han W, He Z, Zhou L (2014) Risk factors and treatment outcomes of new contralateral upper urinary urothelial carcinoma after nephroureterectomy: the experiences of a large Chinese center. J Cancer Res Clin Oncol 140(3):477–485CrossRefPubMed
5.
go back to reference Roupret M, Babjuk M, Comperat E, Zigeuner R, Sylvester RJ, Burger M, Cowan NC, Bohle A, Van Rhijn BW, Kaasinen E, Palou J, Shariat SF (2015) European Association of Urology Guidelines on upper urinary tract urothelial cell carcinoma: 2015 update. Eur Urol 68(5):868–879CrossRefPubMed Roupret M, Babjuk M, Comperat E, Zigeuner R, Sylvester RJ, Burger M, Cowan NC, Bohle A, Van Rhijn BW, Kaasinen E, Palou J, Shariat SF (2015) European Association of Urology Guidelines on upper urinary tract urothelial cell carcinoma: 2015 update. Eur Urol 68(5):868–879CrossRefPubMed
6.
go back to reference Adamis S, Varkarakis J (2011) Minimally invasive approach in the management of upper- urinary-tract tumours. Scand J Urol Nephrol 45(6):381–387CrossRefPubMed Adamis S, Varkarakis J (2011) Minimally invasive approach in the management of upper- urinary-tract tumours. Scand J Urol Nephrol 45(6):381–387CrossRefPubMed
7.
go back to reference Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17(10):2937–2944CrossRefPubMed Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17(10):2937–2944CrossRefPubMed
8.
go back to reference Kang CH, Yu TJ, Hsieh HH, Yang JW, Shu K, Huang CC, Chiang PH, Shiue YL (2003) The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 98(8):1620–1626CrossRefPubMed Kang CH, Yu TJ, Hsieh HH, Yang JW, Shu K, Huang CC, Chiang PH, Shiue YL (2003) The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 98(8):1620–1626CrossRefPubMed
9.
go back to reference Wu CF, Chang PL, Chen CS, Chuang CK, Weng HH, Pang ST (2006) The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma. J Urol 176(2):477–481CrossRefPubMed Wu CF, Chang PL, Chen CS, Chuang CK, Weng HH, Pang ST (2006) The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma. J Urol 176(2):477–481CrossRefPubMed
10.
go back to reference Silberstein JL, Power NE, Savage C, Tarin TV, Favaretto RL, Su D, Kaag MG, Herr HW, Dalbagni G (2012) Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma. J Urol 187(2):429–434CrossRefPubMed Silberstein JL, Power NE, Savage C, Tarin TV, Favaretto RL, Su D, Kaag MG, Herr HW, Dalbagni G (2012) Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma. J Urol 187(2):429–434CrossRefPubMed
11.
go back to reference Stewart JH, Vajdic CM, van Leeuwen MT, Amin J, Webster AC, Chapman JR, McDonald SP, Grulich AE, McCredie MR (2009) The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant 24(10):3225–3231CrossRefPubMed Stewart JH, Vajdic CM, van Leeuwen MT, Amin J, Webster AC, Chapman JR, McDonald SP, Grulich AE, McCredie MR (2009) The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant 24(10):3225–3231CrossRefPubMed
12.
go back to reference Li XB, Xing NZ, Wang Y, Hu XP, Yin H, Zhang XD (2008) Transitional cell carcinoma in renal transplant recipients: a single center experience. Int J Urol 15(1):53–57CrossRefPubMed Li XB, Xing NZ, Wang Y, Hu XP, Yin H, Zhang XD (2008) Transitional cell carcinoma in renal transplant recipients: a single center experience. Int J Urol 15(1):53–57CrossRefPubMed
13.
go back to reference Li HZ, Xia M, Han Y, Xu XG, Zhang YS (2009) De novo urothelial carcinoma in kidney transplantation patients with end-stage aristolochic acid nephropathy in China. Urol Int 83(2):200–205CrossRefPubMed Li HZ, Xia M, Han Y, Xu XG, Zhang YS (2009) De novo urothelial carcinoma in kidney transplantation patients with end-stage aristolochic acid nephropathy in China. Urol Int 83(2):200–205CrossRefPubMed
14.
go back to reference Wu MJ, Lian JD, Yang CR, Cheng CH, Chen CH, Lee WC, Shu KH, Tang MJ (2004) High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan. Am J Kidney Dis 43(6):1091–1097CrossRefPubMed Wu MJ, Lian JD, Yang CR, Cheng CH, Chen CH, Lee WC, Shu KH, Tang MJ (2004) High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan. Am J Kidney Dis 43(6):1091–1097CrossRefPubMed
15.
go back to reference Milenkovic-Petronic D, Milojevic B, Djokic M, Sipetic-Grujicic S, Milojevic IG, Bumbasirevic U, Dzamic Z (2014) The impact of tumor size on outcomes in patients with upper urinary tract urothelial carcinoma. Int Urol Nephrol 46(3):563–569CrossRefPubMed Milenkovic-Petronic D, Milojevic B, Djokic M, Sipetic-Grujicic S, Milojevic IG, Bumbasirevic U, Dzamic Z (2014) The impact of tumor size on outcomes in patients with upper urinary tract urothelial carcinoma. Int Urol Nephrol 46(3):563–569CrossRefPubMed
16.
go back to reference Espiritu PN, Sverrisson EF, Sexton WJ, Pow-Sang JM, Poch MA, Dhillon J, Spiess PE (2014) Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection. Urol Oncol 32(5):619–624CrossRefPubMed Espiritu PN, Sverrisson EF, Sexton WJ, Pow-Sang JM, Poch MA, Dhillon J, Spiess PE (2014) Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection. Urol Oncol 32(5):619–624CrossRefPubMed
17.
go back to reference Pieras E, Frontera G, Ruiz X, Vicens A, Ozonas M, Piza P (2010) Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma. BJU Int 106(9):1319–1323CrossRefPubMed Pieras E, Frontera G, Ruiz X, Vicens A, Ozonas M, Piza P (2010) Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma. BJU Int 106(9):1319–1323CrossRefPubMed
18.
go back to reference Shariat SF, Godoy G, Lotan Y, Droller M, Karakiewicz PI, Raman JD, Isbarn H, Weizer A, Remzi M, Roscigno M, Kikuchi E, Bolenz C, Bensalah K, Koppie TM, Kassouf W, Wheat JC, Zigeuner R, Langner C, Wood CG, Margulis V (2010) Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int 105(12):1672–1677CrossRefPubMed Shariat SF, Godoy G, Lotan Y, Droller M, Karakiewicz PI, Raman JD, Isbarn H, Weizer A, Remzi M, Roscigno M, Kikuchi E, Bolenz C, Bensalah K, Koppie TM, Kassouf W, Wheat JC, Zigeuner R, Langner C, Wood CG, Margulis V (2010) Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int 105(12):1672–1677CrossRefPubMed
19.
go back to reference Chromecki TF, Ehdaie B, Novara G, Pummer K, Zigeuner R, Seitz C, Pycha A, Lee RK, Cha EK, Karakiewicz PI, Ng C, Raman JD, Chun FK, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Bastian PJ, Martinez-Salamanca JI, Scherr DS, Shariat SF (2011) Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy. World J Urol 29(4):473–480CrossRefPubMed Chromecki TF, Ehdaie B, Novara G, Pummer K, Zigeuner R, Seitz C, Pycha A, Lee RK, Cha EK, Karakiewicz PI, Ng C, Raman JD, Chun FK, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Bastian PJ, Martinez-Salamanca JI, Scherr DS, Shariat SF (2011) Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy. World J Urol 29(4):473–480CrossRefPubMed
20.
go back to reference Nielsen ME, Shariat SF, Karakiewicz PI, Lotan Y, Rogers CG, Amiel GE, Bastian PJ, Vazina A, Gupta A, Lerner SP, Sagalowsky AI, Schoenberg MP, Palapattu GS, Bladder Cancer Research Consortium (BCRC) (2007) Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 51(3):699–706 (discussion 706–708) Nielsen ME, Shariat SF, Karakiewicz PI, Lotan Y, Rogers CG, Amiel GE, Bastian PJ, Vazina A, Gupta A, Lerner SP, Sagalowsky AI, Schoenberg MP, Palapattu GS, Bladder Cancer Research Consortium (BCRC) (2007) Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 51(3):699–706 (discussion 706–708)
21.
go back to reference Colin P, Ouzzane A, Pignot G, Ravier E, Crouzet S, Ariane MM, Audouin M, Neuzillet Y, Albouy B, Hurel S, Saint F, Guillotreau J, Guy L, Bigot P, De La Taille A, Arroua F, Marchand C, Matte A, Fais PO, Roupret M, French Collaborative National Database on U.U.T.U.C. (2012) Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study. BJU Int 110(8):1134–1141 Colin P, Ouzzane A, Pignot G, Ravier E, Crouzet S, Ariane MM, Audouin M, Neuzillet Y, Albouy B, Hurel S, Saint F, Guillotreau J, Guy L, Bigot P, De La Taille A, Arroua F, Marchand C, Matte A, Fais PO, Roupret M, French Collaborative National Database on U.U.T.U.C. (2012) Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study. BJU Int 110(8):1134–1141
22.
go back to reference Gadzinski AJ, Roberts WW, Faerber GJ, Wolf JS Jr (2010) Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma. J Urol 183(6):2148–2153CrossRefPubMed Gadzinski AJ, Roberts WW, Faerber GJ, Wolf JS Jr (2010) Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma. J Urol 183(6):2148–2153CrossRefPubMed
Metadata
Title
Treatment strategies for upper tract urothelial carcinoma (UTUC) of a solitary kidney: a single-institutional analysis of 61 cases
Authors
Xiaohong Su
Dong Fang
Lei Zhang
Gengyan Xiong
Han Hao
Guangzhi Zhao
Kunlin Yang
Yunchao Xing
Xuesong Li
Liqun Zhou
Publication date
01-10-2016
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 10/2016
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1353-5

Other articles of this Issue 10/2016

International Urology and Nephrology 10/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.